Status:

TERMINATED

Granulocytapheresis in Psoriasis

Lead Sponsor:

EXcorLab GmbH

Collaborating Sponsors:

Membrana GmbH

Nikkiso Co. Ltd

Conditions:

Psoriasis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

In a prospective, randomized, controlled, double-blinded, multicenter study, granulocytapheresis using a novel cellulose-based adsorber will be compared to control sham treatment (placebo). The effect...

Eligibility Criteria

Inclusion

  • Moderate to severe plaque psoriasis with a PASI \>/=10
  • Age \>/= 18 years
  • Negative pregnancy test in woman of childbearing age acceptable method of contraception for both men and women
  • Written informed consent that can be withdrawn at any time or for any reason
  • Discontinuation of any systemic psoriasis treatment. Washout period of at least two weeks for prior systemic medications
  • Only emollients for topical treatment
  • No vaccinations for at least 14 days prior to first treatment

Exclusion

  • Other forms of psoriasis (e.g., guttate, pustular, erythrodermic, palmoplantar etc.)
  • History of ongoing uncontrolled bacterial, fungal or viral infection (including opportunistic infections); HIV positivity
  • Pregnancy
  • Clinically relevant thrombocytopenia or bleeding disorders
  • WBC \<4.000 or \>12.000/µl
  • Malignancy within the last five years (exception: successfully treated basal cell carcinoma or squamous cell carcinoma of the skin)
  • Severe cardiac disorders, stroke, pulmonary disease within the last year
  • Any medical condition that, in the judgment of the investigators, would jeopardize the patient's safety during the study

Key Trial Info

Start Date :

February 18 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2009

Estimated Enrollment :

4 Patients enrolled

Trial Details

Trial ID

NCT00714272

Start Date

February 18 2008

End Date

January 1 2009

Last Update

August 14 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of Würzburg, Department of Medicine, Division of Nephrology, and Department of Dermatology

Würzburg, Bavaria, Germany, 97080

2

University of Göttingen, Department of Dermatology and Department of Nephrology and Rheumatology

Göttingen, Lower Saxony, Germany, 37075